Skip to main content

Advertisement

Table 2 Allelic distribution of HLA-C in patients and controls

From: HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis

HLA-C allele Psoriasis (n = 45) PsA (n = 100) Controls (n = 177)
Cw*0102 5 (11) 10 (10) 13 (7)
Cw*0202 4 (9) 8 (8) 9 (5)
Cw*0303 3 (7) 11 (11) 19 (11)
Cw*0304 2 (4) 4 (4) 15 (8)
Cw*0401 7 (15) 23 (23) 50 (28)
Cw*0501 4 (9) 9 (9) 30 (17)
Cw*0602 26 (58)a 58 (58)b 32 (18)
Cw*0701 9 (20) 19 (19)c 54 (31)
Cw*0702 7 (15) 17 (17) 45 (25)
Cw*0802 2 (4) 3 (3)d 17 (10)
Cw*1203 3 (7) 3 (3) 6 (3)
Cw*1402 1 (2) 4 (4) 9 (5)
Cw*1502 4 (9) 5 (5) 13 (7)
Cw*1601 2 (4) 4 (4) 15 (8)
Cw*1602 - - 2 (1)
  1. HLA, human leukocyte antigen; PsA, psoriatic arthritis. Results in parentheses are percentages. aOdds ratio (OR) 6.2 (95% confidence interval (CI) 3.1 to 12.5; p < 0.0001); bOR 6.2 (95% CI 3.6 to 10.8; p < 0.0001); cOR 0.5 (95% CI 0.3 to 0.9; p = 0.04); dOR 0.3 (95% CI 0.08 to 1.00; p = 0.05).